Alnylam issues 2021 corporate responsibility report

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, today published its 2021 corporate responsibility report. this year's edition, which is the company's first full report, presents findings from its inaugural materiality assessment, enhances transparency with environmental disclosures aligned to gri and sasb frameworks, highlights how the structure of corporate responsibility has strengthened across the company, and details pr
ALNY Ratings Summary
ALNY Quant Ranking